On May 10, 2021 Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, reported that it will participate in the following investor conferences in the month of May, with presentations led by the Company’s President and Chief Executive Officer, Rodney Varner (Press release, Genprex, MAY 10, 2021, View Source [SID1234579636]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Diamond Equity Emerging Growth Invitational (Virtual)

Presentation Date: May 11, 2021

Presentation Time: 11-11:25 a.m. ET

Registration Link: https://bit.ly/3aZAmXy

Benzinga Small Cap Conference (Virtual)

Presentation Date: May 14, 2021

Presentation Time: 12:45-1:05 p.m. ET

Registration Link: https://bit.ly/3aJeyzq

CEO Roadshow Webinar Series (Virtual)

Date: Once per week, each Thursday, from April 22 through June 10, 2021

Time: Thursdays from 11-11:30 a.m. EDT

Webinar Link: https://bit.ly/3eoHeie

An archive of the conference presentations will be available for a period of time using the registration links above or will be made available for replay on the Company’s website (www.genprex.com) for a period of time following the conferences.